Fidelity Investments’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.74K Sell
266
-92
-26% -$572 ﹤0.01% 5049
2025
Q4
$2.05K Sell
358
-662
-65% -$4.08K ﹤0.01% 5011
2025
Q3
$6.96K Hold
1,020
﹤0.01% 4701
2025
Q2
$9.16K Sell
1,020
-802
-44% -$4.75K ﹤0.01% 4551
2025
Q1
$9.8K Buy
1,822
+1,389
+321% +$9.44K ﹤0.01% 4504
2024
Q4
$3.23K Sell
433
-202
-32% -$1.66K ﹤0.01% 4742
2024
Q3
$5.74K Buy
635
+345
+119% +$3.56K ﹤0.01% 4592
2024
Q2
$3.08K Buy
290
+287
+9,567% +$3.06K ﹤0.01% 4650
2024
Q1
$25 Buy
+3
New +$24 ﹤0.01% 5151
2022
Q4
Sell
-1,000
Closed -$5K 5599
2022
Q3
$5K Buy
+1,000
New +$4.73K ﹤0.01% 4339

Other funds holding ULBI

Fidelity Investments's ULBI Position: Q1 2026 in Review

Fidelity Investments reduced its Ultralife (ULBI) stake by 26% in Q1 2026, selling an estimated $572 and leaving 266 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #5049.

Fidelity Investments first reported a position in ULBI in Q3 2022 and has held it in 10 quarters since. The position peaked at $9.8K in Q1 2025. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Fidelity Investments held 266 shares of Ultralife worth $1.74K as of Q1 2026.
  • Fidelity Investments sold 92 Ultralife shares in Q1 2026, an estimated $572.
  • Ultralife made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5049 holding.
  • Fidelity Investments first reported a position in Ultralife in Q3 2022 and has held it in 10 quarters since.
  • Fidelity Investments's Ultralife position peaked at $9.8K in Q1 2025.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.